Multiple sclerosis affects roughly 1 in 400 to 1 in 500 people in the United States

The most commonly cited estimate is that between 900,000 and 1.1 million Americans have MS, though the exact number is difficult to pin down because MS is not a reportable disease—doctors are not required to register diagnoses with a central agency. The numbers come from surveys, insurance claims analysis, and research studies that try to count cases across the country. Different studies produce slightly different totals depending on how they define MS and who they include.

Globally, MS affects an estimated 2.9 million people. The disease is far more common in some parts of the world than others. Northern Europe, North America, and Australia have the highest rates. MS is less common in Asia, Africa, and Latin America, though it does occur in those regions.

Within the United States, MS is not evenly distributed. Rates are higher in the northern states and lower in the southern states. This pattern has been observed for decades and is not fully understood, though researchers have proposed theories involving vitamin D exposure, latitude-related sunlight, and genetic ancestry of regional populations.

Key Takeaways

  • Between 900,000 and 1.1 million Americans are estimated to have MS, making it roughly 1 in 400 to 1 in 500 people.
  • MS is more common in northern U.S. states and less common in southern states, a pattern that has held for many decades.
  • Globally, MS affects about 2.9 million people, with the highest rates in Northern Europe, North America, and Australia.
  • The exact number of people with MS in the U.S. is not known because MS diagnoses are not tracked by a central registry.

Who gets MS and at what age

MS can develop at any age, but it most commonly appears between ages 20 and 50. The average age of diagnosis is around 34. Children and teenagers can develop MS, though this is less common—pediatric MS accounts for roughly 2 to 5 percent of all MS cases. People over 50 can also develop MS, but new diagnoses become less frequent with age.

Women are diagnosed with MS about two to three times more often than men. This difference is consistent across most countries and age groups. Researchers do not yet know why women develop MS at higher rates, though hormonal, genetic, and immune system factors are all being studied.

MS occurs across all racial and ethnic groups in the United States. However, the disease is diagnosed more frequently in people of Northern European ancestry. Black Americans, Hispanic Americans, and Asian Americans develop MS at lower rates overall, though the reasons for these differences are not completely understood and may involve both genetic and environmental factors.

How MS rates have changed over time

The number of people diagnosed with MS has increased over the past several decades. This rise reflects several factors: better diagnostic tools and imaging technology, greater awareness among doctors and patients, improved access to neurologists in some areas, and possibly genuine increases in disease occurrence. It is difficult to separate how much of the increase is due to better detection versus actual increases in the disease.

The age at which people are diagnosed has also shifted slightly. More people are being diagnosed at younger ages now than in previous decades, which may reflect earlier recognition of symptoms or changes in disease patterns.

Survival rates for people with MS have improved significantly. Decades ago, MS was often considered a rapidly disabling disease. Today, with disease-modifying treatments available, many people with MS have longer periods without worsening symptoms and better long-term outcomes. This does not mean MS is cured, but the trajectory of the disease has changed for many people who receive treatment.

Regional differences in MS rates across the United States

The north-south gradient in MS rates is one of the most consistent patterns in the disease's geography. Northern states like Minnesota, Wisconsin, and the Northeast have historically had higher rates of MS. Southern states like Texas, Florida, and the Deep South have lower rates. This pattern has been documented in multiple large studies over many years.

Researchers have proposed several explanations. One theory involves vitamin D: people in northern climates receive less sunlight year-round, which may affect vitamin D production and immune function. Another theory focuses on genetic ancestry—populations with Northern European heritage have higher MS rates, and these populations are more concentrated in northern U.S. states. A third possibility is that environmental exposures or infections vary by region in ways that influence MS risk.

The gradient is not absolute. Some northern areas have lower-than-expected rates, and some southern areas have higher rates. This suggests that latitude alone does not determine MS risk, and that local factors—whether genetic, environmental, or related to healthcare access—also play a role.

How MS prevalence compares to other neurological diseases

MS is one of the more common neurological diseases affecting young and middle-aged adults, but it is less common than some other conditions. Parkinson's disease affects roughly 1 million Americans, similar to MS. Alzheimer's disease and other dementias are far more common, affecting millions of Americans, but these typically appear later in life. Epilepsy affects about 1.2 million Americans and can occur at any age.

Among autoimmune neurological diseases specifically, MS is the most common. Other autoimmune conditions affecting the nervous system, such as neuromyelitis optica spectrum disorder (NMOSD) or myasthenia gravis, are significantly rarer. This makes MS the leading autoimmune neurological disease in terms of how many people it affects.

Why counting MS cases is difficult

Unlike some diseases, MS is not tracked through a national registry. Doctors diagnose MS based on clinical symptoms, imaging results, and lab tests, but they report these diagnoses to insurance companies and medical records—not to a central government database. This means researchers must piece together estimates from multiple sources.

Different studies use different methods. Some analyze insurance claims data, which captures people with insurance but may miss uninsured or underinsured people. Others conduct population surveys, which can have response bias. Some use hospital discharge data or neurology clinic records. Each method produces slightly different numbers, which is why estimates vary.

Additionally, MS can be difficult to diagnose, especially early in the disease. Some people may have MS but not yet know it. Others may be misdiagnosed with MS when they have a different condition. These diagnostic uncertainties add to the challenge of counting cases accurately.

What the numbers mean for understanding MS risk

Knowing that MS affects roughly 1 in 400 to 1 in 500 Americans tells you that it is not rare, but it is not common either. For most people, MS is not a disease they will develop. However, for people with a family history of MS, the risk is higher—having a first-degree relative with MS increases your own risk, though most people with a family history never develop the disease.

The higher rates in women and in people of Northern European ancestry reflect real patterns, but they do not mean that MS only affects these groups. MS occurs across all demographics. If you have symptoms that concern you—such as vision changes, numbness, weakness, or balance problems—those symptoms warrant evaluation by a neurologist regardless of your age, sex, or background.

The increase in diagnoses over time is partly good news: it means more people are being identified and can access treatment. Earlier diagnosis and treatment can change the course of MS for many people, making it important to seek evaluation if symptoms suggest a neurological problem.

Frequently Asked Questions

Is MS becoming more common?

Diagnoses of MS have increased over recent decades, but it is unclear whether this reflects more people actually developing MS or better detection and awareness. Improved MRI technology, greater recognition of MS symptoms by doctors, and increased access to neurologists have all contributed to higher diagnosis rates. Some research suggests genuine increases in MS occurrence, but the evidence is not conclusive.

Can you inherit MS from a parent?

MS is not directly inherited like some genetic diseases. However, having a parent or sibling with MS does increase your risk of developing MS compared to the general population. Most people with a family history of MS will never develop the disease. Both genetic and environmental factors appear necessary for MS to develop.

Why do women get MS more often than men?

The reason for the 2-to-3-fold higher rate in women is not fully understood. Hormonal differences, genetic factors, and how the immune system functions differently in women are all being studied. The gap has widened over recent decades, which suggests environmental or social factors may also play a role, but research is ongoing.

Is MS more common in certain countries?

Yes. MS is most common in Northern Europe, North America, and Australia. It is less common in Asia, Africa, and Latin America. Within countries, rates often vary by region—in the U.S., northern states have higher rates than southern states. These geographic patterns suggest that latitude, sunlight exposure, genetic ancestry, and possibly environmental factors all influence MS occurrence.

If I have symptoms, does the prevalence of MS affect my chances of having it?

No. Prevalence describes how common a disease is in a population, but it does not predict whether you personally have it. If you have neurological symptoms like vision problems, numbness, weakness, or balance issues, those symptoms warrant evaluation by a neurologist regardless of how common MS is overall. A doctor will assess your individual situation, not population statistics.